How do accelerated approval and priority review expedite cancer drug approval?
Accelerated approval and priority review are special programs designed to expedite the approval of drugs that address unmet medical needs or offer significant benefits over existing treatments. [Accelerated approval](https://www.fda.gov) allows drugs to be approved based on surrogate endpoints that predict clinical benefit, while priority review shortens the review period, ensuring faster access to potentially life-saving treatments for patients.
